CLISEQ is developing a next-generation blood-based diagnostic platform that aims to replace invasive bone marrow biopsies with comprehensive single-cell analysis from peripheral blood. Leveraging advanced single-cell sequencing and high-resolution molecular profiling developed at the Weizmann Institute in collaboration with 10x Genomics, the platform enables earlier detection, more precise disease classification, and longitudinal monitoring for hematologic disorders through a simple blood draw.